On 16 August 2019, by electronic vote, the Global Fund Board approved funding for three country grants worth $32.7 million (Colombia HIV, Honduras TB/HIV and Kazakhstan TB). Domestic commitments for the programs included in the approved country grants amounted to $1.17 billion. Initiatives valued at $2.4 million were added to the Unfunded Quality Demand (UQD) Register. (See Table 1.)
You are here
West and Central Africa is one of the most challenging regions for Global Fund grants. A recent Office of the Inspector General (OIG) advisory review found that weak health systems and insufficient monitoring are linked to low grant execution and slow progress against the diseases.
On 31 January 2019, the Global Fund Board approved three country grants worth $13.4 million. It also approved two multicountry grants valued at $22.5 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). See Tables 1 and 2 for listings of the country and multi-country grants.
As part of a larger package of approvals in December, the Global Fund Board approved a $36.4 grant known as the Middle East Response. This is the second time the several-country arrangement has been funded as such, but now includes an expanded remit.
On 21 December 2018, the Global Fund Board approved 16 country grants worth $229.4 million. It also approved three multi-country grants valued at $24.0 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC).
Global Fund multi-country program in East Africa spearheads trip to China to learn about harm reduction technologies
As Global Fund multi-country grants enter a new phase, we map all ongoing and planned regional and multi-country grants
Global Fund Board approves fifth batch of country grants from 2017-2019 allocations, in the amount of $1.22 billion
On 12 January 2018, the Global Fund Board approved 33 country grants worth $1.22 billion. This was the fifth batch of approvals from the 2017–2019 allocations, and brings the cumulative amount awarded to date to $8.86 billion.
On 13-14 November 2017, a consultation took place in Minsk, Belarus, co-organized by the Eastern Europe and Central Asia (EECA) team at the Global Fund Secretariat and the UNAIDS Regional Office for EECA, to discuss with regional stakeholders the terms of reference (TOR) for next round of multi-country HIV projects for the EECA region to be financed by the Global Fund.